Date of Award
Open Access Thesis
Master of Science (MS)
Marcia M. Pierce
Oliver R. Oakley
Rebekah L. Waikel
Antibiotic-resistant bacteria have become an increasing burden worldwide. A highly resistant species is Pseudomonas aeruginosa, a nosocomial pathogen that produces a biofilm that enhances its resistance. This project examined the possibility of using bacteriocin, an internal protective toxin produced by some species of bacteria, as a potential treatment for resistant bacteria. In this study, standard broad spectrum antibiotics were used to treat P. aeruginosa to prevent biofilm formation. The biofilm was then analyzed to determine if the biofilm is inhibited or facilitated by each treatment. Optimal concentrations of antibiotics were determined to be effective at a concentration of 0.07mg/mL for gentamicin, rifampicin, and polymyxin B. These antibiotics were used to test 48 clinical samples obtained in 2006. Out of the 48 isolates, a Pseudomonas strain of unknown origin was resistant to both gentamicin and rifampicin (p<0.001). Extraction of Colicin V from E. coli and Pyocin S2 from P. aeruginosa was unsuccessful. Nanodrop analysis determined that there was minimal protein in each sample (concentrations between 0.196-3.118mg/mL). In the future, bacteriocin extractions should be successfully performed, and analysis of further biofilm assays will determine the overall benefit of the treatment.
Copyright 2015 Courtney Paige Turpin
Turpin, Courtney Paige, "The effect of antibiotics on Pseudomonas aeruginosa biofilm production" (2015). Online Theses and Dissertations. 323.